ATAI Life Sciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $40 | $273 | $0 | $18 |
Gross Profit | 40 | 191 | -83 | -83 |
EBITDA | -22,602 | -56,674 | -24,911 | -17,528 |
EBIT | -22,685 | -56,756 | -24,994 | -17,629 |
Net Income | -26,286 | -57,312 | -26,713 | -18,292 |
Net Change In Cash | 40 | 273 | 0 | 18 |
Free Cash Flow | -19,342 | -16,228 | -22,578 | -21,110 |
Cash | 29,963 | 19,333 | 23,867 | 45,034 |
Basic Shares | 160,621 | 160,387 | 158,891 | 158,842 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $314 | $233 | $20,376 | $19,880 |
Gross Profit | -5 | 65 | 20,329 | -24 |
EBITDA | -36,311 | -135,014 | -120,278 | -92,118 |
EBIT | -36,630 | -135,182 | -120,325 | -92,142 |
Net Income | -40,224 | -141,411 | -132,612 | -102,118 |
Net Change In Cash | 314 | 233 | 20,376 | 19,880 |
Cost of Revenue | -170,530 | |||
Free Cash Flow | -84,708 | -105,491 | -64,374 | -20,825 |
Cash | 45,034 | 190,613 | 362,266 | 97,246 |
Basic Shares | 158,833 | 155,719 | 160,677 | 5,813 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.16 |
2024-06-30 | -$0.36 |
2024-03-31 | -$0.17 |
2023-12-31 | -$0.12 |
